|
How Equity Crowdfunding Can Help Life Science Companies |
|
After five challenging years raising capital for early-stage biotechs, the industry has seen a paradigm shift in non-traditional sources of start-up financing. The successful funding of the antibacterial drug discovery company, ANTABIO, via crowdfunding platform WiSEED, as well as the popularity of Kickstarter and the important passage of the JOBS Act, are just a few examples of this trend. http://www.healthiosxchange.com/documents/2/202/how-equity-crowdfunding-can-help-life-science-companies Are your portfolio companies seeking development funding? Or, are you interested in advising them on utilizing crowdfunding to help them meet their capital demands? Register for the 2014 BIO Investor Forum by August 22nd and receive a free copy of the BIO/ShareVault Whitepaper: How Equity Crowdfunding Can Help Life Science Companies*. The 13th Annual BIO Investor Forum is an international biotech investor conference focused on investment strategies, trends and opportunities for the industry's most transformational and established private companies as well as emerging public companies.
http://www.bio.org/events/conferences/bio-investor-forum-general-registration?utm_source=Highroads&utm_medium=email&utm_campaign=2014-08-07-BIF-Whitepaper&utm_term=Register-Now-BTN
Please join HealthiosXchange by clicking http://www.healthiosxchange.com/signup?ref=3
Learn more about HealthiosXchange here: http://www.healthiosxchange.com/pages/who-we-are
Learn more about Investors Syndicates here: http://www.healthiosxchange.com/pages/how-it-works-for-syndicates |